Annals of Surgical Oncology Sign the Guestbook
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Raspagliesi, F.
Right arrow Articles by De Palo, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Raspagliesi, F.
Right arrow Articles by De Palo, G.

Annals of Surgical Oncology, Vol 7, Issue 10 738-742, Copyright © 2000 by Society of Surgical Oncology

ARTICLES

Prognostic indicators in melanoma of the vulva

F. Raspagliesi, A. Ditto, D. Paladini, R. Fontanelli, B. Stefanon, S. Dipalma and G. De Palo
Department of Gynecologic Oncology, Istituto Nazionale Tumori, Milan, Italy. dittotony@hotmail.com

BACKGROUND: The aim of this study was to evaluate the prognostic significance of clinical-pathologic variables in melanoma of the vulva. METHODS: From 1979 through 1995, 40 women with a diagnosis of vulvar melanoma underwent radical surgery. Patient age, tumor size and site, histologic type, ulceration, tumor thickness, lymph node status, and number of positive lymph nodes were assessed for prognostic significance by multivariate analysis. RESULTS: Tumor thickness was a significant predictor of lymph node involvement, but not of survival. The most powerful predictors of survival by multivariate analysis were the lymph node status (P = .002) and the number of positive lymph nodes (P = .00003). CONCLUSIONS: The number of positive lymph nodes represents the strongest prognostic factor in melanoma of the vulva. Because of the lack of effective adjuvant therapies, such prognostic indicators might be used to define the timing and extent of the surgical approach.


This article has been cited by other articles:


Home page
 Obstet GynecolHome page
V. E. Sugiyama, J. K. Chan, J. Y. Shin, J. S. Berek, K. Osann, and D. S. Kapp
Vulvar Melanoma: A Multivariable Analysis of 644 Patients
Obstet. Gynecol., August 1, 2007; 110(2): 296 - 301.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
R. L. Coleman
Vulvar Lymphatic Mapping: Coming of Age?
Ann. Surg. Oncol., November 1, 2002; 9(9): 823 - 825.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2000 by the Society of Surgical Oncology.